Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
C10B C10B Lipid modifying agents, combinations
C10BA C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents
C10BA01 C10BA01 lovastatin and nicotinic acid
C10BA02 C10BA02 simvastatin and ezetimibe
C10BA03 C10BA03 pravastatin and fenofibrate
C10BA04 C10BA04 Simvastatin and Fenofibrate
C10BA05 C10BA05 atorvastatin and ezetimibe
C10BA06 C10BA06 rosuvastatin and ezetimibe
C10BA07 C10BA07 Rosuvastatin And Omega-3 Fatty Acids
C10BA08 C10BA08 Atorvastatin And Omega-3 Fatty Acids
C10BA09 C10BA09 Rosuvastatin And Fenofibrate
C10BX C10BX HMG CoA reductase inhibitors, other combinations
C10BX01 C10BX01 simvastatin and acetylsalicylic acid
C10BX02 C10BX02 pravastatin and acetylsalicylic acid
C10BX03 C10BX03 atorvastatin and amlodipine
C10BX04 C10BX04 simvastatin, acetylsalicylic acid and ramipril
C10BX05 C10BX05 rosuvastatin and acetylsalicylic acid
C10BX06 C10BX06 atorvastatin, acetylsalicylic acid and ramipril
C10BX07 C10BX07 rosuvastatin, amlodipine and lisinopril
C10BX08 C10BX08 atorvastatin and acetylsalicylic acid
C10BX09 C10BX09 rosuvastatin and amlodipine
C10BX10 C10BX10 rosuvastatin and valsartan
C10BX11 C10BX11 atorvastatin, amlodipine and perindopril
C10BX12 C10BX12 atorvastatin, acetylsalicylic acid and perindopril
C10BX13 C10BX13 Rosuvastatin, Perindopril And Indapamide
C10BX14 C10BX14 Rosuvastatin, Amlodipine And Perindopril
C10BX15 C10BX15 Atorvastatin And Perindopril
C10BX16 C10BX16 Rosuvastatin And Fimasartan
C10BX17 C10BX17 Rosuvastatin And Ramipril
D D Dermatologicals
Showing 30 of 6753 Records